As one of Germany's senior cardiologists, Professor Franz-Josef Neumann played a pivotal role in the merger of two of the country's major cardiac centres to form the University Heart Center Freiburg, Bad Krozingen - Germany.
It is the latest phase of a career that has also included important research which linked reversible ischaemia and inflammation and also studies that established dual antiplatelet therapy for stent placement as the standard of care.
A member of the International Editorial Board of the European Heart Journal, he was born and brought up in Aachen, where his father was a technician at the Department of Physics of the University of Aachen, and educated at an ‘old-fashioned grammar school’ in the city where he enjoyed ‘getting in touch with the thoughts of the ancient Romans and Greeks’.
He studied medicine at the University of Aachen, spending his final year at Westminster Medical School in London where his academic teachers gave him the enthusiasm to pursue a career in cardiology.
In 1991, Professor Albert Schömig, Chair of Cardiology at the University of Munich, offered Professor Neumann the position of Senior Staff Physician and Head of the Catheterization Laboratory. He then became Associate Professor of Clinical and Interventional Cardiology at the Technical University of Munich in 1996.
Of the people who have shaped his career, he believes Professor Schömig was the biggest influence.
In October 2001, he became the Medical Director and Chairman of the Heart Center Bad Krozingen, which was already one of the biggest heart centres in Germany, and in 2012 merged his centre with the cardiovascular departments of the Medical Faculty of the University of Freiburg to form the University Heart Center Freiburg, Bad Krozingen.
Currently, Medical Director of the Division of Cardiology and Angiology II and serves as Deputy Medical Director of the University Heart Center Freiburg · Bad Krozingen, he is also Endowed Professor of Cardiovascular Medicine of the University of Freiburg.
Other research for Professor Neumann is around optimization of reperfusion in myocardial infarction as well fostering the research groups within his institution in the field of electrophysiology, heart failure and interventional angiology.
Will COMPARE-ACUTE change my practice?
19 May 2017 – From EuroPCR 2017
The year in intervention: essential publications from the EuroIntervention Journal and the European Heart Journal
18 May 2017 – From EuroPCR 2017
The Synergy stent: complete revascularisation solutions in complex PCI
16 May 2017 – From EuroPCR 2017
The Synergy stent: expanding treatment options in complex PCI
17 May 2016 – From EuroPCR 2016
Different scenarii in NSTEMI-PCI
22 May 2015 – From EuroPCR 2015
Adjunctive thrombotic treatment in ACS
22 May 2014 – From EuroPCR 2014
Individualised antiplatelet therapy based on testing or genotyping: idea from the past or solution for the future
22 May 2013 – From EuroPCR 2013